NeoPharm CO. LTD (092730) - Total Liabilities

Latest as of September 2025: ₩18.97 Billion KRW ≈ $12.86 Million USD

Based on the latest financial reports, NeoPharm CO. LTD (092730) has total liabilities worth ₩18.97 Billion KRW (≈ $12.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore NeoPharm CO. LTD long-term investment allocation to see how much of total assets are deployed in long-term investments.

NeoPharm CO. LTD - Total Liabilities Trend (2012–2024)

This chart illustrates how NeoPharm CO. LTD's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see NeoPharm CO. LTD total assets.

NeoPharm CO. LTD Competitors by Total Liabilities

The table below lists competitors of NeoPharm CO. LTD ranked by their total liabilities.

Company	Country	Total Liabilities
Dongsung Corporation KO:102260	Korea	₩506.98 Billion
Monte Carlo Fashions Limited NSE:MONTECARLO	India	Rs11.19 Billion
Duluth Holdings Inc NASDAQ:DLTH	USA	$236.49 Million
Unic Technology TWO:5452	Taiwan	NT$2.21 Billion
Kunyue Development Co Ltd TWO:5206	Taiwan	NT$13.49 Billion
Thien Viet Securities JSC VN:TVS	Vietnam	₫4.17 Trillion
T.K.S. Technologies Public Company Limited BK:TKS	Thailand	฿1.04 Billion
City Lodge Hotels Ltd JSE:CLH	South Africa	ZAC1.96 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down NeoPharm CO. LTD's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See NeoPharm CO. LTD (092730) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	9.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NeoPharm CO. LTD's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NeoPharm CO. LTD (2012–2024)

The table below shows the annual total liabilities of NeoPharm CO. LTD from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩15.56 Billion ≈ $10.54 Million	-10.77%
2023-12-31	₩17.43 Billion ≈ $11.81 Million	+32.70%
2022-12-31	₩13.14 Billion ≈ $8.90 Million	+0.26%
2021-12-31	₩13.10 Billion ≈ $8.88 Million	-14.14%
2020-12-31	₩15.26 Billion ≈ $10.34 Million	-10.49%
2019-12-31	₩17.05 Billion ≈ $11.55 Million	+24.98%
2018-12-31	₩13.64 Billion ≈ $9.24 Million	+49.69%
2017-12-31	₩9.11 Billion ≈ $6.18 Million	+14.80%
2016-12-31	₩7.94 Billion ≈ $5.38 Million	+1.96%
2015-12-31	₩7.79 Billion ≈ $5.28 Million	+84.58%
2012-12-31	₩4.22 Billion ≈ $2.86 Million	--

About NeoPharm CO. LTD

KQ:092730 Korea Personal & Household Products & Services

Market Cap

$124.25 Million

₩183.34 Billion KRW

Market Cap Rank

#18463 Global

#832 in Korea

Share Price

₩22950.00

Change (1 day)

+5.52%

52-Week Range

₩15760.00 - ₩25450.00

All Time High

₩27383.15